![]() | KAEF - Kimia Farma Tbk. | KAEF - Kimia Farma Tbk. | KAEF - Kimia Farma Tbk. | |
Sector | : | Healthcare | ||
Sub Sector | : | Pharmaceuticals and Health Care Research | ||
Industry | : | Pharmaceuticals | ||
Sub Industry | : | Pharmaceuticals | ||
Index (4) | : | COMPOSITE, IDXHEALTH, IDXSMC-COM, DBX | ||
Index (4) | : | COMPOSITE, IDXHEALTH, IDXSMC-COM, DBX | ||
Board | : | 4 Index COMPOSITE, IDXHEALTH, IDXSMC-COM, DBX | ||
Fasilitas Marjin | : | Saham yang tidak dapat diperdagangkan dengan menggunakan fasilitas marjin | ||
Pre Opening | : | Saham dapat diperdagangan melalui sesi Pre-opening | ||
Corporate Action | : | - | ||
RATING & BTO MATRIX | ||||||
---|---|---|---|---|---|---|
Benchmark to Others : | ||||||
A Exceptional | ||||||
B Excellent | ||||||
C Very Good | ||||||
D Good | ||||||
E Fair | ||||||
F Poor | ![]() |
|||||
RATING | ||||||
RATING | 0 | 1 | 2 | 3 | 4 | 5 |
RATING | 0 | 1 | 2 | 3 | 4 | 5 |
RATING FUNDAMENTAL | ||
---|---|---|
Rating EPS | 0 | |
Rating ROA | 0 | |
Rating EQUITY | 1 | |
Rating ROE | 0 | |
Rating DER | 3 | |
Rating TOTAL | 0 |
MARKET CAPITALIZATION | ||
Listed Share | 5.566.585.107 | |
Price | Rp. 525 | |
Capitalization | Rp. 2.922.457.181.175 | |
OWNERSHIP | ||
Listing Date : 04-Jul-01 | ||
Lokal 10,12 % | Asing 0,05 % | Lainnya 89,83 % |
![]() | KAEF - Kimia Farma Tbk. | KAEF - Kimia Farma Tbk. | KAEF - Kimia Farma Tbk. | |
Sector | : | Healthcare | ||
Sub Sector | : | Pharmaceuticals and Health Care Research | ||
Industry | : | Pharmaceuticals | ||
Sub Industry | : | Pharmaceuticals | ||
Index (4) | : | COMPOSITE, IDXHEALTH, IDXSMC-COM, DBX | ||
Index (4) | : | COMPOSITE, IDXHEALTH, IDXSMC-COM, DBX | ||
Board | : | 4 Index COMPOSITE, IDXHEALTH, IDXSMC-COM, DBX | ||
Fasilitas Marjin | : | Saham yang tidak dapat diperdagangkan dengan menggunakan fasilitas marjin | ||
Pre Opening | : | Saham dapat diperdagangan melalui sesi Pre-opening | ||
Corporate Action | : | - | ||
Description | 3Q18 | 3Q19 | 3Q20 | 3Q21 | 3Q22 | 3Q23 | 3Q24 | CAGR 5Y(%) |
Last Price | 2550 | 2900 | 2890 | 2400 | 1250 | 805 | 625 | |
Market Cap | 14.2 T | 16.1 T | 16.1 T | 13.3 T | 6.9 T | 4.5 T | 3.5 T | -78.26 |
BALANCE SHEET | ||||||||
Cash | 1.4 T | 574.3 B | 749.8 B | 661.1 B | 734.3 B | 792.7 B | 505.1 B | -12.05 |
Total Asset | 8.6 T | 17.9 T | 17.7 T | 18.8 T | 18.7 T | 20.6 T | 16.8 T | -6.15 |
S.T.Borrowing | 3.8 T | 6.3 T | 7.3 T | 7.3 T | 7.0 T | 8.8 T | 7.8 T | |
L.T.Borrowing | 2.1 T | 3.6 T | 3.5 T | 4.3 T | 4.3 T | 2.3 T | 3.3 T | |
Total Equity | 2.8 T | 7.9 T | 6.9 T | 7.2 T | 7.3 T | 9.4 T | 5.7 T | -27.85 |
INCOME STATEMENT | ||||||||
Revenue | 6.0 T | 6.9 T | 7.0 T | 9.5 T | 7.1 T | 7.7 T | 7.9 T | 14.49 |
Gross Profit | 2.4 T | 2.5 T | 2.6 T | 3.3 T | 2.5 T | 2.8 T | 2.4 T | -4.00 |
Operating Profit | 598.1 B | 429.1 B | 504.5 B | 825.2 B | 136.4 B | 240.6 B | -197.5 B | -146.03 |
Net.Profit | 225.5 B | 41.8 B | 37.2 B | 301.9 B | -180.9 B | -177.4 B | -421.8 B | -1109.09 |
EBITDA | 687.0 B | 583.2 B | 638.4 B | 1.1 T | 565.4 B | 484.7 B | -6.9 B | -101.18 |
Interest Expense | 149.1 B | 357.1 B | 447.8 B | 448.5 B | 374.7 B | 410.4 B | 442.2 B | |
RATIO | ||||||||
EPS | 40.26 | 7.47 | 6.64 | 53.92 | -32.31 | -31.67 | -75.33 | -1108.43 |
PER | 63.34 x | 388.22 x | 435.24 x | 44.51 x | -38.69 x | -25.42 x | -8.30 x | |
BVPS | 501.28 | 1423.63 | 1245.1 | 1303.61 | 1312.68 | 1697.48 | 1025.57 | |
PBV | 5.09 x | 2.04 x | 2.32 x | 1.84 x | 0.95 x | 0.47 x | 0.61 x | |
ROA | 0.0261 | 0.0023 | 0.0021 | 0.016 | -0.0097 | -0.0086 | -0.0251 | -1191.30 |
ROE | 0.081 | 0.0053 | 0.0054 | 0.0417 | -0.0248 | -0.0188 | -0.0739 | -1494.34 |
EV/EBITDA | 27.13 | 43.71 | 40.84 | 22.64 | 31.08 | 30.52 | -2031.3 | |
Debt/Equity | 2.1 | 1.26 | 1.56 | 1.6 | 1.56 | 1.18 | 1.94 | |
Debt/TotalCap | 0.68 | 0.56 | 0.61 | 0.62 | 0.61 | 0.54 | 0.66 | |
Debt/EBITDA | 8.5 | 17.07 | 16.87 | 10.83 | 20.1 | 22.92 | -1601.86 | |
EBITDA/IntExps | 4.61 | 1.63 | 1.43 | 2.39 | 1.51 | 1.18 | -0.02 | -101.23 |
RATING & BTO MATRIX | ||||||
---|---|---|---|---|---|---|
Benchmark to Others : | ||||||
A Exceptional | ||||||
B Excellent | ||||||
C Very Good | ||||||
D Good | ||||||
E Fair | ||||||
F Poor | ![]() |
|||||
RATING | ||||||
RATING | 0 | 1 | 2 | 3 | 4 | 5 |
RATING | 0 | 1 | 2 | 3 | 4 | 5 |
MARKET CAPITALIZATION | ||
Listed Share | 5.566.585.107 | |
Price | Rp. 525 | |
Capitalization | Rp. 2.922 B. | |
OWNERSHIP | ||
Listing Date : 04-Jul-01 | ||
Lokal 10,12 % | Asing 0,05 % | Lainnya 89,83 % |
RATING FUNDAMENTAL | ||
---|---|---|
Rating EPS | 0 | |
Rating ROA | 0 | |
Rating EQUITY | 1 | |
Rating ROE | 0 | |
Rating DER | 3 | |
Rating TOTAL | 0 |
![]() | KAEF - Kimia Farma Tbk. | KAEF - Kimia Farma Tbk. | KAEF - Kimia Farma Tbk. | |
Sector | : | Healthcare | ||
Sub Sector | : | Pharmaceuticals and Health Care Research | ||
Industry | : | Pharmaceuticals | ||
Sub Industry | : | Pharmaceuticals | ||
Index (4) | : | COMPOSITE, IDXHEALTH, IDXSMC-COM, DBX | ||
Index (4) | : | COMPOSITE, IDXHEALTH, IDXSMC-COM, DBX | ||
Board | : | 4 Index COMPOSITE, IDXHEALTH, IDXSMC-COM, DBX | ||
Fasilitas Marjin | : | Saham yang tidak dapat diperdagangkan dengan menggunakan fasilitas marjin | ||
Pre Opening | : | Saham dapat diperdagangan melalui sesi Pre-opening | ||
Corporate Action | : | - | ||
TIME PERIOD : 07-03-2025 | |||
Close | 525 | Prev Close | 525 |
Change | - | Range | 510-535 |
Bid | 520 | Offer | 525 |
Bid Volume | 2000 | Offer Volume | 10900 |
Frequency | 290 | Value Rp.: 223.496.500 |
RETURN ON ASSET | |||||
---|---|---|---|---|---|
Benchmark to Others : | |||||
A Exceptional | |||||
B Excellent | |||||
C Very Good | |||||
D Good | |||||
E Fair | |||||
F Poor | ![]() |
||||
RATIO (%) | ≤ 0 |
0-0.4 | 0.4- 1.7 |
1.7- 3.6 |
> 3.6 |
RATING & BTO MATRIX | ||||||
---|---|---|---|---|---|---|
Benchmark to Others : | ||||||
A Exceptional | ||||||
B Excellent | ||||||
C Very Good | ||||||
D Good | ||||||
E Fair | ||||||
F Poor | ![]() |
|||||
RATING | ||||||
RATING | 0 | 1 | 2 | 3 | 4 | 5 |
RATING | 0 | 1 | 2 | 3 | 4 | 5 |